MDY Mdy Healthcare

RNS No 6882u
MEDISYS PLC
24 May 1999

                                 Medisys PLC

           US DISTRIBUTION AGREEMENT FOR NICSAFE SYSTEM SIGNED
                  WITH PHYSICIAN'S SUPPLY AND SERVICE INC.

Medisys PLC is pleased to announce that its Lukens Medical Corporation
subsidiary has signed a US distribution agreement for its NicSafe needle
disposal system with Physicians Sales and Service, Inc. ("PSS").

PSS, a division of PSS World Medical, Inc., is the largest distributor of
medical supplies and equipment to office-based physicians in the United
States.  Headquartered in Jacksonville, Florida, PSS operates from 56
distribution centres, and its 730 sales representatives service over 100,000
office sites in all 50 states.

PSS World Medical, with annual sales of $1.4 billion, is also the largest US
distributor of medical supplies and related products to the long-term care
industry, and the largest distributor of medical diagnostic imaging supplies,
chemicals, equipment, and service to the acute care and alternate-care
markets. 

The NicSafe, marketed by Medisys subsidiary Lukens Medical Corp., is an FDA
approved needle destruction system, with a base unit and a disposable
cartridge, which holds the debris of 500 needles. 

Kurt E. Amundson, President and Chief Operating Officer of Medisys, said "We
are delighted to enter into this agreement with PSS, the leading supplier of
physicians offices in the US market.  The NicSafe needle disposal system
provides instant, cost effective needle destruction at the point of use and
reduces risk of needlestick injury, which affects approximately 1 million US
healthcare workers annually.

"California, Tennessee and Maryland have recently passed legislation mandating
needlestick injury prevention technology, and 18 additional states are
currently considering similar measures.  The NicSafe system offers PSS
customers an ideal solution to enhance safety, contain costs, and comply with
the new legislation."

Note to editors:

Medisys PLC develops, manufactures and markets diagnostic, medical and safety
products serving the rapid test and point of care medical market.  The Group
has two principal operating subsidiaries, Hypoguard and Lukens, located in the
UK and in the US respectively.  The diagnostic division develops and supplies
blood glucose monitoring systems for the diabetic market.  Its future focus is
on serving unmet medical needs through the development of diagnostic products
based on its own proprietary platform technologies.  Headquartered in Ipswich,
UK, the Group employs approximately 225 people in the UK and US.

Enquiries:

Medisys PLC                            
Kurt Amundson, President & Chief Operating Officer       001 650 327 7900
Michael Barry, Chief Financial Officer                   001 770 271 2795

Square Mile Communications                                  0171 601 1000
Kevin Smith


END

MSCGLGZKRDFLLMG

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024